An Award-Winning CDMO Specializing in Pharmaceutical Product Development
UPM Pharmaceuticals is a pharmaceutical product development company. We’re a bit of a rarity in the industry — an independent, family-owned contract development and manufacturing organization with the commercial pedigree of 80 products brought to market, and longstanding experience as a Big Pharma supplier.
ABOUT UPMAs a pharmaceutical productions contract development and manufacturing organization, we produce semi-solid and solid dose drug products. We also have a particularly robust track record in late‑stage commercial production, including tech transfers and scale-up capabilities.
Annual Production Capabilities
3.5B
Tablets
680M
Capsules
1,300
Metric Tons of Semi-Solids
At UPM, we work with other pharmaceutical companies to provide comprehensive CDMO pharma manufacturing, from pharmaceutical product development through analytical testing. Over the last few decades, we have honed our expertise to specialize in the intricate processes involved in potent handling, hormones and DEA-licensed controlled substances. Our full pharmaceuticals services process can also support commercial transfer projects in both oral solids and semi-solids, involving up to hundreds of millions of doses annually.
UPM Pharmaceuticals has been owned and operated primarily by the same family business legacy for more than 25 years as one of the leading pharmaceutical manufacturers. Our nearly 500,000-square-foot facility has seen over 80 compounds advanced from proof of concept to commercialization and continues to manufacture several commercialized pharma solutions and CDMO pharmaceutical products.
FACILITY OVERVIEWFacility At A Glance
475,000 ft2
Commercial Pharma Manufacturing Facility
250,000 ft2
Warehouse
15,800 ft2
DEA-Approved Vault Space
7-Acre
Pharmaceutical Development Campus
What We're Talking About
Pharma's Almanac
Advancing Commercial Manufacturing from Orphan Drugs to Blockbusters